Your browser doesn't support javascript.
loading
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.
Brastianos, Priscilla K; Kim, Albert E; Giobbie-Hurder, Anita; Lee, Eudocia Quant; Wang, Nancy; Eichler, April F; Chukwueke, Ugonma; Forst, Deborah A; Arrillaga-Romany, Isabel C; Dietrich, Jorg; Corbin, Zachary; Moliterno, Jennifer; Baehring, Joachim; White, Michael; Lou, Kevin W; Larson, Juliana; de Sauvage, Magali A; Evancic, Kathryn; Mora, Joana; Nayyar, Naema; Loeffler, Jay; Oh, Kevin; Shih, Helen A; Curry, William T; Cahill, Daniel P; Barker, Fred G; Gerstner, Elizabeth R; Santagata, Sandro.
Afiliación
  • Brastianos PK; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA. pbrastianos@mgh.harvard.edu.
  • Kim AE; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Giobbie-Hurder A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Lee EQ; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Wang N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Eichler AF; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Chukwueke U; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Forst DA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Arrillaga-Romany IC; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Dietrich J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Corbin Z; The Chenevert Family Brain Tumor Center, Smilow Cancer Hospital and Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Moliterno J; The Chenevert Family Brain Tumor Center, Smilow Cancer Hospital and Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • Baehring J; The Chenevert Family Brain Tumor Center, Smilow Cancer Hospital and Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
  • White M; Wilmot Cancer Center, University of Rochester, Division of Neuro-Oncology, Rochester, NY, USA.
  • Lou KW; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Larson J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • de Sauvage MA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Evancic K; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Mora J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Nayyar N; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Loeffler J; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Oh K; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Shih HA; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Curry WT; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Cahill DP; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Barker FG; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Gerstner ER; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
  • Santagata S; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Nat Commun ; 13(1): 1325, 2022 03 14.
Article en En | MEDLINE | ID: mdl-35289329

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Meníngeas / Meningioma Límite: Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos